Spots Global Cancer Trial Database for toxicities
Every month we try and update this database with for toxicities cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas | NCT00047879 | Glioma | PEG-interferon ... Thalidomide | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of Life | NCT01930981 | Hematologic Mal... Other Diagnoses... | 19 Years - | Fred Hutchinson Cancer Center | ||
| FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases in the Thorax | NCT05524064 | Bone Metastases... | FLASH Radiother... | 18 Years - | Varian, a Siemens Healthineers Company | |
| Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases | NCT04592887 | Bone Metastasis | FLASH Radiother... | 18 Years - | Varian, a Siemens Healthineers Company | |
| Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas | NCT00047879 | Glioma | PEG-interferon ... Thalidomide | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of Life | NCT01930981 | Hematologic Mal... Other Diagnoses... | 19 Years - | Fred Hutchinson Cancer Center | ||
| Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric Cancer | NCT00595985 | Gastric Cancer | sorafenib | 18 Years - 70 Years | Fudan University | |
| Boron Neutron Capture Therapy (BNCT) for Locally Recurrent Head and Neck Cancer | NCT01173172 | Head and Neck C... | Boron Neutron C... | 18 Years - 80 Years | Taipei Veterans General Hospital, Taiwan | |
| Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC | NCT00767377 | Gastric Cancer | EOF5 | 18 Years - 75 Years | Fudan University | |
| Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients | NCT05595109 | Breast Cancer Peripheral Neur... Cardiac Toxicit... Hepatic Toxicit... Cognitive Impai... | Silymarin Placebo | 18 Years - | Tanta University | |
| Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer | NCT04227886 | Rectal Neoplasm... Chemoradiothera... Neoadjuvant The... Predictive Biom... Adenocarcinoma | Radiation Capecitabine-Ir... | 18 Years - 75 Years | Fudan University | |
| Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer | NCT00595972 | Gastric Cancer | ECF-endostar | 18 Years - 70 Years | Fudan University | |
| Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases | NCT04592887 | Bone Metastasis | FLASH Radiother... | 18 Years - | Varian, a Siemens Healthineers Company | |
| Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer | NCT04227886 | Rectal Neoplasm... Chemoradiothera... Neoadjuvant The... Predictive Biom... Adenocarcinoma | Radiation Capecitabine-Ir... | 18 Years - 75 Years | Fudan University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
